Illumina Body Map 2
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_217560248 Show fit | 1.13 |
ENST00000233813.4
|
insulin-like growth factor binding protein 5 |
|
chr1_+_77333117 Show fit | 0.98 |
ENST00000477717.1
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
|
chr1_-_117210290 Show fit | 0.87 |
ENST00000369483.1
ENST00000369486.3 |
immunoglobulin superfamily, member 3 |
|
chr2_+_176957619 Show fit | 0.80 |
ENST00000392539.3
|
homeobox D13 |
|
chr6_-_29527702 Show fit | 0.78 |
ENST00000377050.4
|
ubiquitin D |
|
chr20_-_14318248 Show fit | 0.70 |
ENST00000378053.3
ENST00000341420.4 |
fibronectin leucine rich transmembrane protein 3 |
|
chr4_+_55524085 Show fit | 0.69 |
ENST00000412167.2
ENST00000288135.5 |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
chr2_+_14772810 Show fit | 0.69 |
ENST00000295092.2
ENST00000331243.4 |
family with sequence similarity 84, member A |
|
chr13_+_98794810 Show fit | 0.66 |
ENST00000595437.1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
|
chr3_-_57199397 Show fit | 0.66 |
ENST00000296318.7
|
interleukin 17 receptor D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 1.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.7 | GO:0038162 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.6 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-11 complex(GO:0043260) |
0.2 | 0.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.0 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |